Stocktoria

Citius Pharmaceuticals, Inc. CTXR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-08-03 · LEI

Citius Pharmaceuticals, Inc. statistics & valuation

P / B0.2×
Return on capital-44.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-19972.60% -18385.50% -17331.50% -19678.50% -26146.50% -37017.80% 2016201720182019202020212022202320242025
Return on equity (%)
-49.50% -47.30% -40.90% -57.30% -52.10% -17.40% -32.50% -35.60% 2016201720182019202020212022202320242025
Shares outstanding
4.9M 8.3M 16.2M 28.9M 55.6M 146.0M 146.2M 6.4M 7.2M 18.1M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-37.80% -42.50% -40.40% -42.40% -40.10% -16.20% -29.50% -31.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-15946.70% -18813.90% -26952.60% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.23 -$0.23 -$5.57 -$5.97 -$3.38 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-37017.8%-26146.5%-19678.5%-17331.5%-18385.5%-19972.6%
Net margin-37378.5%-25616.0%-19497.9%-17291.3%-16715.5%-20769.9%
FCF margin-26952.6%-18813.9%-15946.7%
Return on assets-31.4%-29.5%-16.2%-40.1%-42.4%-40.4%-42.5%-37.8%
Return on equity-35.6%-32.5%-17.4%-52.1%-57.3%-40.9%-47.3%-49.5%
Current ratio0.620.405.959.8418.283.411.723.161.390.17

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.